Where is SpringWorks headquartered?

SpringWorks is located in Baltimore, MD.

Who invested in SpringWorks?

SpringWorks has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for SpringWorks?

SpringWorks closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

springworkstx.com

SpringWorks

SpringWorks develops and commercializes clinical drug therapies for the treatment of cancer, oncology and rare genetic diseases.

Business Model:

Revenue: $35M

Employees: 51-200

Geographic Data

Address: 100 International Drive

City: Baltimore

State: MD

Zip: 21202

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$287M

Raised Total:

$515M

Social

Twitter

Crunchbase

Metrics

2,279,655Website Global Rank

8,320Website Monthly Traffic

Twitter Followers

Description

SpringWorks develops and commercializes clinical drug therapies for the treatment of cancer, oncology and rare genetic diseases.

Contact Phone:
+19173308560

Contact Email:

IPO Details

SpringWorks went public on 9/12/2019 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
9/12/2019

IPO Valuation:
$752M

Ticker Symbol:
SWTX

IPO Price:
$18/share

Amount Raised:
$162M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
3/2019	Series B		$125M	Perceptive Advisors OrbiMed Advisors Bain Capital HBM Healthcare Investments Pfizer GlaxoSmithKline
9/2019	IPO		$162M
9/2022	Private Placement		$225M
10/2020	Post-IPO Equity		$287.5M
9/2022	Post-IPO Equity	5	$225M	Perceptive Advisors Invus Opportunities EcoR1 Capital Deerfield Management Boxer Capital Perceptive Advisors Invus Opportunities EcoR1 Capital Deerfield Management Boxer Capital
9/2017	Series A	5	$103M	Pfizer Venture Investments OrbiMed LifeArc Bain Capital Life Sciences Bain Capital Double Impact Fund
4/2019	Series B	10	$125M	GlaxoSmithKline Pfizer Venture Investments LifeArc HBM Healthcare Investments AG Bain Capital Perceptive Advisors Laurion Capital Management ArrowMark Partners OrbiMed Samsara BioCapital Perceptive Advisors Pfizer Venture Investments LifeArc HBM Healthcare Investments AG Bain Capital GlaxoSmithKline Perceptive Advisors Laurion Capital Management ArrowMark Partners OrbiMed Samsara BioCapital Perceptive Advisors

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details